Congratulations to our ASCENT Virtual Pitch Event winner, CEREBRO Therapeutics Inc., led by Martin Levesque!

Earlier today, we had the privilege of
watching our nine ASCENT companies deliver high-impact virtual pitches to a panel of distinguished judges from …

We’re excited to announce our upcoming Virtual Pitch Competition as part of the CBV ASCENT Program!

Nine high-potential companies from our current cohort will take the virtual stage to pitch their ventures and compete for a coveted pitch prize. These founders are building bold solutions across…

Capital BioVentures (CBV), a leading biotech accelerator, dedicated to supporting the growth of early-stage life sciences companies, is proud to announce the launch of its newest offering, the ASCENT Program…

The Stem Cell Network (SCN) and Capital BioVentures (CBV) are pleased to announce a new partnership to accelerate the development and commercialization of regenerative medicine innovations…

Capital BioVentures (CBV), Ottawa’s Biotech Accelerator Program, proudly announces the first cohort of companies selected for its support programming. Seven innovative enterprises have been chosen…